Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Economic analysis of opportunities to accelerate Alzheimer's disease research and development.

Scott TJ, O'Connor AC, Link AN, Beaulieu TJ.

Ann N Y Acad Sci. 2014 Apr;1313:17-34. doi: 10.1111/nyas.12417. Epub 2014 Mar 27.

2.

Design of a comprehensive Alzheimer's disease clinic and research center in Spain to meet critical patient and family needs.

Boada M, Tárraga L, Hernández I, Valero S, Alegret M, Ruiz A, Lopez OL, Becker JT; Fundació ACE Alzheimer Research Center and Memory Clinic.

Alzheimers Dement. 2014 May;10(3):409-15. doi: 10.1016/j.jalz.2013.03.006. Epub 2013 Sep 10.

3.

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.

Toledo JB, Van Deerlin VM, Lee EB, Suh E, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T, Irwin DJ, Gross RG, Hurtig H, McCluskey L, Elman L, Karlawish J, Schellenberg G, Chen-Plotkin A, Wolk D, Grossman M, Arnold SE, Shaw LM, Lee VM, Trojanowski JQ.

Alzheimers Dement. 2014 Jul;10(4):477-84.e1. doi: 10.1016/j.jalz.2013.06.003. Epub 2013 Aug 24.

4.

A model for improving the treatment and care of Alzheimer's disease patients through interdisciplinary research.

Trojanowski JQ, Arnold SE, Karlawish JH, Naylor M, Brunden KR, Lee VM.

Alzheimers Dement. 2012 Nov;8(6):564-73. doi: 10.1016/j.jalz.2011.08.005.

5.

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.

Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQ.

Alzheimers Dement. 2012 Sep;8(5):445-52. doi: 10.1016/j.jalz.2012.08.001.

6.

Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.

Andersen F, Viitanen M, Halvorsen DS, Straume B, Engstad TA.

BMC Geriatr. 2011 Oct 4;11:58. doi: 10.1186/1471-2318-11-58.

7.

Neurodegenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention.

Trojanowski JQ, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):491-5. doi: 10.1016/j.pneurobio.2011.07.004. Epub 2011 Jul 23. No abstract available.

8.

Building an integrated neurodegenerative disease database at an academic health center.

Xie SX, Baek Y, Grossman M, Arnold SE, Karlawish J, Siderowf A, Hurtig H, Elman L, McCluskey L, Van Deerlin V, Lee VM, Trojanowski JQ.

Alzheimers Dement. 2011 Jul;7(4):e84-93. doi: 10.1016/j.jalz.2010.08.233.

9.

Biomarkers in frontotemporal lobar degenerations--progress and challenges.

Hu WT, Trojanowski JQ, Shaw LM.

Prog Neurobiol. 2011 Dec;95(4):636-48. doi: 10.1016/j.pneurobio.2011.04.012. Epub 2011 Apr 30. Review.

10.

Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs".

Sabbagh MN.

Alzheimers Dement. 2010 Mar;6(2):156-7. doi: 10.1016/j.jalz.2010.01.006. No abstract available.

Supplemental Content

Support Center